2026 ICD-10-CM Diagnosis Code Z08Encounter for follow-up examination after completed treatment for malignant neoplasm

ICD-10-CM CodesZ00–Z99Z00-Z13Z08

ICD-10-CM Z08
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

Z08 is a billable ICD-10-CM diagnosis code for encounter for follow-up examination after completed treatment for malignant neoplasm. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 826 through 830, 837 through 839, 846 through 848. The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Neoplasm-related encounters.

Code Identity

ICD-10-CM Code
Z08
Billable Status
Yes — Valid for Submission
Code Describes
Encounter for follow-up examination after completed treatment for malignant neoplasm
Chapter
Z00-Z13
Persons encountering health services for examinations

Code Classification

ChapterZ00–Z99Factors influencing health status and contact with health services
SectionZ00-Z13Persons encountering health services for examinations
CategoryZ08Encounter for follow-up examination after completed treatment for malignant neoplasm
This CodeZ08Encounter for follow-up examination after completed treatment for malignant neoplasm

Code EditsBilling

Medicare Code Editor checks that affect claim validity for Z08.

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Present on Admission (POA)Billing

Z08 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Medical surveillance following completed treatment

Use Additional Code

  • code to identify any acquired absence of organs Z90

Type 1 Excludes

  • aftercare following medical care Z43 Z49 Z51

Index to Diseases and InjuriesGuidance

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Examination(for) (following) (general) (of) (routine)
      • following
        • treatment (for)
          • combined NEC
            • malignant neoplasm
    • Examination(for) (following) (general) (of) (routine)
      • following
        • treatment (for)
          • malignant neoplasm
    • Examination(for) (following) (general) (of) (routine)
      • follow-up (routine) (following)
        • chemotherapy NEC
          • malignant neoplasm
    • Examination(for) (following) (general) (of) (routine)
      • follow-up (routine) (following)
        • malignant neoplasm
    • Examination(for) (following) (general) (of) (routine)
      • follow-up (routine) (following)
        • radiotherapy NEC
          • malignant neoplasm
    • Examination(for) (following) (general) (of) (routine)
      • follow-up (routine) (following)
        • surgery NEC
          • malignant neoplasm

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR FAC008
Neoplasm-related encounters
Default principal diagnosis: inpatient No · outpatient Yes

Patient EducationClinical

Cancer

Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should.

The full article covers:

  • What is cancer?
  • What are the types of cancer?
  • How does cancer develop?
  • What are the symptoms of cancer?
  • How is cancer diagnosed?
  • What are the treatments for cancer?
  • Can cancer be prevented?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert Z08 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
V67.01 Follow-up vag pap smear
Approximate The match is approximate rather than exact.
ICD-9-CM
V67.1 Radiotherapy follow-up
Approximate The match is approximate rather than exact.
ICD-9-CM
V67.2 Chemotherapy follow-up
Approximate The match is approximate rather than exact.
ICD-9-CM
V67.59 Follow-up exam NEC
Approximate The match is approximate rather than exact.
ICD-9-CM
V67.6 Comb treatment follow-up
Approximate The match is approximate rather than exact.
ICD-9-CM
V67.9 Follow-up exam NOS
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About Z08Overview

Is Z08 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report encounter for follow-up examination after completed treatment for malignant neoplasm on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What MS-DRG does Z08 group to?

On inpatient claims, encounter for follow-up examination after completed treatment for malignant neoplasm maps to MS-DRG 826, 827, 828, 829, 830, 837, 838, 839, 846, 847, 848, with relative weights from 0.8494 to 4.8043 depending on complications. Higher weights mean higher Medicare reimbursement.

Can Z08 be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because encounter for follow-up examination after completed treatment for malignant neoplasm describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.

Is Z08 exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for encounter for follow-up examination after completed treatment for malignant neoplasm on inpatient claims.

What is the ICD-9 equivalent of Z08?

Under the General Equivalence Mappings, encounter for follow-up examination after completed treatment for malignant neoplasm converts to ICD-9-CM V67.01 (follow-up vag pap smear), V67.1 (radiotherapy follow-up), and V67.2 (chemotherapy follow-up). The mapping is approximate, so confirm the match fits the documentation.